Table 4.
Secondary efficacy variables at baseline and after 8 weeks of intervention
| Intervention | OPLE- 500 | OPLE-1000 | FICUS |
|---|---|---|---|
| Body Weight (kg) |
|
|
|
| *Baseline |
87.2±12.4 |
91.4±19.3 |
94.5±14.8 |
|
†Final |
87.1±14.1 |
91.9±19.6 |
95.4±15.7 |
| Change |
0.17±2.04 |
0.58±2.04 |
0.10±1.53 |
| p value for change |
p=0.81 |
p=0.40 |
p=0.41 |
| Waist Circumference (cm) |
|
|
|
| *Baseline |
104±11 |
105±11 |
107±10 |
|
†Final |
101±10 |
101±11 |
107±10 |
| Change |
−2.8±2.4 |
−4.2±3.5 |
−0.4 ±3.5 |
| p value for change | p=0.009 | p=0.004 | p=0.72 |
*Baseline body weight is the weight at the time of time of screening for study eligibility.
Values are given as the mean ± SD.
†Final body weight after 8 weeks of intervention. Values are given as the mean ± SD.
For each continuous variable at each time point, the mean differences in the variable or in the change in that variable from baseline between the different products was tested for nominal significance by the one-way analysis of variance (ANOVA) or by the non-parametric Kruskal-Wallis test if non-normally distributed.